Macroamylase
Macroamylase refers to a high molecular weight complex formed by the binding of serum amylase to immunoglobulins, most commonly IgA and less frequently IgG. These macroamylase complexes are too large to pass through the glomerular filtration barrier and, as a result, accumulate in the bloodstream, leading to persistently elevated serum amylase levels. This condition is not inherently pathogenic but can mimic acute pancreatitis, particularly in cases where patients present with elevated serum amylase but normal serum lipase and urinary amylase, and no clinical symptoms of pancreatitis. An important diagnostic tool in distinguishing macroamylasemia from pancreatitis is the amylase clearance-to-creatinine clearance ratio (ACR). A normal ACR is 2–5%, whereas an ACR of <1% is suggestive of macroamylasemia.
Although macroamylasemia is typically benign and idiopathic, it has been associated with several underlying conditions, including autoimmune diseases (e.g., rheumatoid arthritis, celiac disease), lymphoproliferative disorders (e.g., lymphoma), monoclonal gammopathies, HIV/AIDS, and inflammatory bowel diseases. In these conditions, overproduction of immunoglobulins increases the likelihood of macroamylase complex formation.
- To rule out pancreatitis in cases with elevated serum amylase and no supporting clinical or biochemical evidence
- Useful in differential diagnosis of hyperamylasemia associated with autoimmune or lymphoproliferative diseases
Increased in:
- Autoimmune diseases
- Lymphoproliferative diseases
- HIV
- Celiac disease (untreated)
Decreased in:
- Immunodeficiency
- Renal impairment
Amylase monomeric >71% of total amylase Or absolute range: 23 – 110 U/L
Serum, SST tube.
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: 30 days
- J Clin Lab Anal. 2023 Mar;37(5):e24859. [PMID: 36916750]
- Clin Chem. 1994 Dec;40(12):2254-9. [PMID: 7527307]
- Ital J Gastroenterol Hepatol. 1999 Dec;31(9):846-9. [PMID: 10669992]
- Digestion. 1975;13(1-2):56-75. [PMID: 1104398]